PLoS ONE (Jan 2017)

A preclinical evaluation of alternative site for islet allotransplantation.

  • Chengshi Wang,
  • Xiaojiong Du,
  • Sirong He,
  • Yujia Yuan,
  • Pengfei Han,
  • Dan Wang,
  • Younan Chen,
  • Jingping Liu,
  • Bole Tian,
  • Guang Yang,
  • Shounan Yi,
  • Fabao Gao,
  • Zhihui Zhong,
  • Hongxia Li,
  • Jingqiu Cheng,
  • Yanrong Lu

DOI
https://doi.org/10.1371/journal.pone.0174505
Journal volume & issue
Vol. 12, no. 3
p. e0174505

Abstract

Read online

The bone marrow cavity (BMC) has recently been identified as an alternative site to the liver for islet transplantation. This study aimed to compare the BMC with the liver as an islet allotransplantation site in diabetic monkeys. Diabetes was induced in Rhesus monkeys using streptozocin, and the monkeys were then divided into the following three groups: Group1 (islets transplanted in the liver with immunosuppressant), Group 2 (islets transplanted in the tibial BMC), and Group 3 (islets transplanted in the tibial BMC with immunosuppressant). The C-peptide and blood glucose levels were preoperatively measured. An intravenous glucose tolerance test (IVGTT) was conducted to assess graft function, and complete blood cell counts were performed to assess cell population changes. Cytokine expression was measured using an enzyme-linked immune sorbent assay (ELISA) and MILLIPLEX. Five monkeys in Group 3 exhibited a significantly increased insulin-independent time compared with the other groups (Group 1: 78.2 ± 19.0 days; Group 2: 58.8 ± 17.0 days; Group 3: 189.6 ± 26.2 days) and demonstrated increases in plasma C-peptide 4 months after transplantation. The infusion procedure was not associated with adverse effects. Functional islets in the BMC were observed 225 days after transplantation using the dithizone (DTZ) and insulin/glucagon stains. Our results showed that allogeneic islets transplanted in the BMC of diabetic Rhesus monkeys remained alive and functional for a longer time than those transplanted in the liver. This study was the first successful demonstration of allogeneic islet engraftment in the BMC of non-human primates (NHPs).